John R Koethe Selected Research

Human Immunodeficiency Virus Proteins

1/2020	HIV and antiretroviral therapy-related fat alterations.
1/2020	Hypertension and Metabolic Syndrome in Persons with HIV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John R Koethe Research Topics

Disease

19	Inflammation (Inflammations) 01/2022 - 04/2011
16	Weight Gain 01/2022 - 04/2010
14	HIV Infections (HIV Infection) 01/2022 - 09/2009
10	Obesity 01/2021 - 07/2013
9	Insulin Resistance 01/2022 - 04/2013
8	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 05/2010
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2013
7	Malnutrition (Nutritional Deficiencies) 01/2021 - 09/2009
6	Hypertension (High Blood Pressure) 02/2022 - 01/2019
6	Overweight 01/2021 - 07/2013
4	Viremia 01/2022 - 09/2017
3	Diabetes Mellitus 02/2022 - 05/2016
3	Disease Progression 01/2021 - 11/2011
2	Glucose Intolerance 01/2022 - 01/2018
2	Schistosomiasis (Bilharziasis) 01/2022 - 01/2020
2	Noncommunicable Diseases 01/2021 - 01/2017
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 05/2016
2	Dyslipidemias (Dyslipidemia) 01/2020 - 01/2016
2	Infections 01/2020 - 01/2020
1	Heart Failure 02/2022
1	Peripheral Arterial Disease 02/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2022
1	Atrial Fibrillation 02/2022
1	Atherosclerosis 01/2022
1	Non-alcoholic Fatty Liver Disease 07/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2021
1	Neoplasms (Cancer) 01/2021
1	Atherosclerotic Plaque (Atheroma) 10/2020
1	Substance-Related Disorders (Drug Abuse) 04/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Lipodystrophy 01/2020

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 01/2022 - 04/2013
7	IntegrasesIBA 10/2021 - 12/2017
6	Lipopolysaccharide ReceptorsIBA 01/2022 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2011
5	C-Reactive ProteinIBA 01/2022 - 06/2012
4	efavirenz (Sustiva)FDA Link 01/2022 - 12/2017
4	Tenofovir (Viread)FDA Link 01/2022 - 12/2017
4	Emtricitabine (Emtriva)FDA Link 01/2022 - 12/2017
4	Integrase InhibitorsIBA 10/2021 - 01/2020
4	NucleosidesIBA 12/2020 - 05/2016
4	Reverse Transcriptase InhibitorsIBA 12/2020 - 05/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2013
3	LeptinIBA 01/2022 - 06/2012
3	CytokinesIBA 01/2022 - 07/2013
3	AdipokinesIBA 01/2022 - 10/2016
3	AcidsIBA 01/2022 - 05/2016
3	RNA (Ribonucleic Acid)IBA 12/2020 - 04/2020
3	Protease Inhibitors (Protease Inhibitor)IBA 12/2020 - 01/2018
3	dolutegravirIBA 12/2020 - 12/2017
3	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 01/2016
2	HDL LipoproteinsIBA 02/2022 - 01/2021
2	AdiponectinIBA 01/2022 - 01/2019
2	Epoxide HydrolasesIBA 01/2022 - 01/2021
2	abacavir (Ziagen)FDA Link 10/2021 - 12/2020
2	SaltsIBA 01/2021 - 07/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 12/2020 - 01/2020
2	tenofovir alafenamideIBA 12/2020 - 01/2020
2	Human Immunodeficiency Virus ProteinsIBA 01/2020 - 01/2020
2	Immunologic Factors (Immunomodulators)IBA 01/2020 - 01/2020
2	ThymidineIBA 01/2020 - 01/2018
2	AntigensIBA 11/2018 - 01/2018
2	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2018 - 05/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 01/2015
2	Viral ProteinsIBA 09/2017 - 10/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 07/2013
2	Phosphates (Orthophosphate)IBA 01/2013 - 05/2010
1	Triglycerides (Triacylglycerol)IBA 02/2022
1	Raltegravir Potassium FDA Link 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2022
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2022
1	Darunavir (Prezista)FDA Link 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	EnzymesIBA 01/2022
1	Ritonavir (Norvir)FDA Link 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	LysophospholipidsIBA 01/2021
1	3-nitrotyrosineIBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	Anabolic AgentsIBA 01/2021
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2021
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	N- ((4- cyano- 2- (trifluoromethyl)phenyl)methyl)- 3- ((4- methyl- 6- (methylamino)- 1,3,5- triazin- 2- yl)amino)cyclohexanecarboxamideIBA 01/2021
1	Appetite StimulantsIBA 01/2021
1	Rilpivirine (TMC-278)IBA 12/2020
1	Zidovudine (Retrovir)FDA LinkGeneric 12/2020
1	CobicistatIBA 12/2020
1	bictegravirIBA 12/2020
1	elvitegravirIBA 12/2020
1	NucleotidesIBA 12/2020
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Praziquantel (Biltricide)FDA Link 01/2020

Therapy/Procedure

32	Art Therapy 01/2022 - 09/2009
25	Therapeutics 01/2022 - 04/2010
4	Highly Active Antiretroviral Therapy (HAART) 10/2021 - 07/2011